Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Thumbnail

Benefits of intensive BP therapy outweigh risks in octogenarians

Taking steps to keep older patients’ systolic blood pressure under the 120 mmHg mark could lower those patients’ risk of MI, stroke, death and mild cognitive impairment, according to a new study—but it could also fast-track a decline in kidney health.

Thumbnail

Long work hours linked to higher BP

Working long hours was linked to as much as a 70% increased risk of masked hypertension and a 66% greater risk of sustained hypertension in a recent study of 3,500 white-collar employees in Quebec, Canada.

Thumbnail

Researchers ID novel apolipoprotein, antibody complex as CVD biomarker

Research led by a team at the University of Kentucky and funded by the American Heart Association and National Institutes of Health has uncovered a new biomarker for cardiovascular disease: an apolipoprotein/antibody combo.

Thumbnail

Cleaner diets could save the US $50B

Switching to a healthier diet could save Americans more than $300 annually and could cut U.S. healthcare costs by $50 billion, a new study suggests.

Thumbnail

AHA awards $14M in grants for diabetes research

The American Heart Association on Dec. 13 announced that it would be awarding more than $14 million in research grants to advance its new Strategically Focused Research Network on Cardiometabolic Health and Type 2 Diabetes.

Thumbnail

Antiarrhythmic drug could also treat PAH, COPD

An FDA-approved antiarrhythmic drug known as dofetilide could be repurposed to treat pulmonary arterial hypertension, researchers have found.

Thumbnail

Evolocumab plus high-intensity statin therapy effectively lowers LDL-C

A study published in JACC suggests that, when combined with high-intensity statin therapy, evolocumab can be an effective tool for lowering LDL-cholesterol in patients who have experienced an acute coronary syndrome.

Thumbnail

FDA testing metformin for carcinogens

The FDA is testing metformin, a popular drug used to treat type 2 diabetes, for carcinogenic impurities.